Vinayak Doraiswamy - Mar 1, 2024 Form 4 Insider Report for AtriCure, Inc. (ATRC)

Role
Chief Scientific Officer
Signature
/s/ Vinayak S. Doraiswamy
Stock symbol
ATRC
Transactions as of
Mar 1, 2024
Transactions value $
-$321,259
Form type
4
Date filed
3/5/2024, 04:44 PM
Previous filing
Jul 3, 2023
Next filing
Jul 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRC Common Stock Award $0 +19.3K +49.08% $0.00 58.6K Mar 1, 2024 Direct F1
transaction ATRC Common Stock Award $0 +9.33K +15.92% $0.00 67.9K Mar 1, 2024 Direct F2
transaction ATRC Common Stock Tax liability -$321K -8.86K -13.04% $36.28 59.1K Mar 1, 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.
F2 The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.
F3 The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.